文献速递前列腺增生与排尿功能障碍

术前逼尿肌活动低下对前列腺增生PV与HoLEP术后5年疗效的影响

Effect of preoperative detrusor underactivity on long-term surgical outcomes of photovaporization and holmium laser enucleation in men with benign prostatic hyperplasia: a lesson from 5-year serial follow-up data.
PubMed 文献 · BJU Int · 2019-01-27

本研究纳入245例BPH患者(PV 143例、HoLEP 102例),按术前逼尿肌活动低下(DU,BCI<100)分组,比较术后5年系列随访结局。DU患者PV或HoLEP术后排尿症状、QoL和PVR改善可维持至5年,但排尿症状与尿流率随时间恶化在DU组更明显;HoLEP与较高基线BCI是5年LUTS改善的独立预测因素。

要点

  • DU患者PV或HoLEP术后排尿症状、QoL及PVR改善可维持至5年。
  • 术后长期随访中排尿症状与尿流率恶化在DU患者中更明显。
  • HoLEP与较高基线BCI是术后5年LUTS改善的独立预测因素。

核心结论

  • DU患者PV或HoLEP术后排尿症状、QoL和PVR改善总体可维持至5年。
  • PV或HoLEP术后长期随访中排尿症状和尿流率恶化在DU患者中更明显。
  • BPH伴DU患者可能从HoLEP更彻底切除前列腺腺瘤及较高基线膀胱收缩力中获益。

研究设计与样本

  • 纳入245例有完整5年随访数据的BPH患者,PV使用120W-HPS者143例,HoLEP者102例。
  • 按术前DU状态分组:PV-HPS-DU(+)114例、PV-HPS-DU(-)29例、HoLEP-DU(+)56例、HoLEP-DU(-)46例。
  • 以膀胱收缩力指数(BCI)<100定义为DU。
  • 比较术后6个月及1、2、3、4、5年的IPSS、尿流率和血清PSA等系列结局。
  • LUTS改善定义为总IPSS较基线下降≥50%。

主要发现

  • PV-HPS-DU(+)与PV-HPS-DU(-)组总IPSS、QoL指数和PVR改善维持至术后5年,但Qmax和膀胱排尿效率除外。
  • HoLEP-DU(+)与HoLEP-DU(-)组所有结局变量的改善维持至术后5年。
  • 术后长期随访中排尿症状亚评分、总IPSS和Qmax随时间恶化在PV-HPS-DU(+)与HoLEP-DU(+)组较对应DU(-)组更明显。
  • 整个随访期间HoLEP-DU(+)组排尿症状亚评分、总IPSS、QoL指数和血清PSA下降幅度大于PV-HPS-DU(+)组。
  • 手术类型(HoLEP vs PV)和较高基线BCI是术后5年LUTS改善的独立预测因素。

关键数值与推荐

  • DU定义:膀胱收缩力指数(BCI)<100。
  • LUTS改善定义:总IPSS较基线下降≥50%。

临床怎么用

  • 对BPH合并DU患者,PV或HoLEP术后排尿症状、QoL和PVR改善可维持至5年。
  • 术后长期随访应关注DU患者排尿症状和尿流率的随时间恶化。
  • BPH伴DU患者选择HoLEP可能较PV更有利于排尿症状和QoL。
  • 基线膀胱收缩力较高者术后5年LUTS改善可能性更大。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To investigate the impact of preoperative detrusor underactivity (DU) on serial treatment outcomes over the course of 5 years after photovaporization (PV) or holmium laser enucleation (HoLEP) in patients with benign prostatic hyperplasia (BPH), to compare its impact after PV vs HoLEP, and to identify predictors of long-term lower urinary tract symptoms (LUTS) improvement. MATERIALS AND METHODS: This study involved 245 patients with BPH who had complete 5-year follow-up data (PV using 120W-HPS, n = 143, HoLEP, n = 102), grouped as follows: PV-HPS-DU(+), n = 114; PV-HPS-DU(-), n = 29; HoLEP-DU(+), n = 56; and HoLEP-DU(-), n = 46. Bladder contractility index (BCI) < 100 was regarded as DU. Serial treatment outcomes for the International Prostate Symptom Score (IPSS) questionnaire, uroflowmetry and serum PSA level at 6 months, and at 1, 2, 3, 4 and 5 years after surgery, were compared among the groups. LUTS improvement was defined as a reduction in total IPSS of ≥50% relative to baseline. RESULTS: Improvement in total IPSS, quality of life (QoL) index and post-void residual urine volume (PVR) in the PV-HPS-DU(+) and PV-HPS-DU(-) groups were maintained up to 5 years after PV, except for maximum urinary flow rate (Qmax ) and bladder voiding efficiency. In the HoLEP-DU(+) and HoLEP-DU(-) groups, improvements in all outcome variables were maintained up to 5 years after HoLEP. Deteriorations in subtotal voiding symptom score, total IPSS and Qmax with time during the long-term period after surgery were more pronounced in the PV-HPS-DU(+) and HoLEP-DU(+) groups than in the PV-HPS-DU(-) and HoLEP-DU(-) groups. Reductions in subtotal voiding symptom score, total IPSS, QoL index, and serum PSA were greater in the HoLEP-DU(+) group than in the PV-HPS-DU(+) group throughout follow-up. The type of surgery (HoLEP vs PV) and higher baseline BCI were independent predictors of LUTS improvement at 5 years after surgery. CONCLUSION: Generally, improvement of micturition symptoms, QoL and PVR in patients with DU appears to be maintained up to 5 years after PV or HoLEP. Deterioration of voiding symptoms and urinary flow rate at long-term follow-up visits after PV or HoLEP was more pronounced in patients with LUTS/BPH with DU than in those without DU. Patients with BPH with DU may benefit from more complete removal of prostatic adenoma by HoLEP and greater baseline bladder contractility in terms of micturition symptoms and QoL.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Cho MC, Yoo S, Park J, et al. Effect of preoperative detrusor underactivity on long-term surgical outcomes of photovaporization and holmium laser enucleation in men with benign prostatic hyperplasia: a lesson from 5-year serial follow-up data. BJU Int. 2019. PMID: 30582661. doi:10.1111/bju.14661

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。